Advances in Carcinogenic Metal Toxicity and Potential Molecular Markers by Koedrith, Preeyaporn & Seo, Young Rok
Int. J. Mol. Sci. 2011, 12, 9576-9595; doi:10.3390/ijms12129576 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Review 
Advances in Carcinogenic Metal Toxicity and Potential 
Molecular Markers 
Preeyaporn Koedrith 
1,2 and Young Rok Seo 
1,2,*
 
1  Department of Life Science, Dongguk University, 30 Pildong-ro 1-gil (26 Pildong 3-ga), Jung-gu, 
Seoul 100-715, Korea; E-Mail: pkoedrith@gmail.com 
2  Institute of Environmental Medicine for Green Chemistry, Dongguk University, 30 Pildong-ro 1-gil 
(26 Pildong 3-ga), Jung-gu, Seoul 100-715, Korea 
*  Author to whom correspondence should be addressed; E-Mail: seoyr@dongguk.edu;  
Tel.: +82-2-2260-3321; Fax: +82-2-2760-0674. 
Received: 13 September 2011; in revised form: 28 October 2011 / Accepted: 12 December 2011 / 
Published: 20 December 2011 
 
Abstract: Metal compounds such as arsenic, cadmium, chromium, cobalt, lead, mercury, 
and nickel are classified as carcinogens affecting human health through occupational  
and environmental exposure. However, the underlying mechanisms involved in tumor 
formation are not well clarified. Interference of metal homeostasis may result in oxidative 
stress which represents an imbalance between production of free radicals and the system’s 
ability to readily detoxify reactive intermediates. This event consequently causes DNA 
damage, lipid peroxidation, protein modification, and possibly symptomatic effects for 
various diseases including cancer. This review discusses predominant modes of action and 
numerous molecular markers. Attention is paid to metal-induced generation of free radicals, 
the phenomenon of oxidative stress, damage to DNA, lipid, and proteins, responsive signal 
transduction pathways with major roles in cell growth and development, and roles of 
antioxidant enzymatic and DNA repair systems. Interaction of non-enzymatic antioxidants 
(carotenoids, flavonoids, glutathione, selenium, vitamin C, vitamin E, and others) with 
cellular oxidative stress markers (catalase, glutathione peroxidase, and superoxide 
dismutase) as well as certain regulatory factors, including AP-1, NF-κB, Ref-1, and p53 is 
also reviewed. Dysregulation of protective pathways, including cellular antioxidant 
network against free radicals as well as DNA repair deficiency is related   
to oncogenic stimulation. These observations provide evidence that emerging oxidative  
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stress-responsive regulatory factors and DNA repair proteins are putative predictive factors 
for tumor initiation and progression. 
Keywords: carcinogenicity; DNA damage; DNA repair; genotoxicity; heavy metal; 
oxidative stress 
 
1. General Features of Carcinogenic Metal Compounds 
Metal compounds are found throughout the environment. Industrial applications contribute 
significantly to human metal exposure. Some metals, including arsenic, cadmium, chromium, cobalt, 
lead, mercury, and nickel have been classified as human carcinogens or considered to be human 
carcinogens by the International Agency for Research on Cancer and by the German MAK Commission. 
Their carcinogenic potentials are predominantly dependent on oxidation state, solubility, and complex 
form. Physicochemical properties control uptake, intracellular transport and distribution, and 
bioavailability [1–3]. Toxic metal ions, with similar properties to essential ions (e.g., charge and size), 
possibly compete with essential ions for biological binding sites, leading to perturbation of biomolecular 
structure and function as well as a disturbance in metal homeostasis [1–3]. Exposure to toxic metals is 
closely associated with the formation of free radicals, directly or indirectly, in living organisms [4–7]. 
The cumulative generation of free radicals, such as reactive oxygen species (ROS) and reactive 
nitrogen species (RNS), is termed oxidative stress and induces a cellular redox imbalance, which is 
linked to cancer incidence [8–10]. The common mode of action for metal-induced carcinogenicity is 
summarized as: (1) Induction of oxidative stress and damage to cellular components, particularly DNA; 
(2) interference with DNA repair systems, resulting in genomic instability; and (3) interruption of cell 
growth and proliferation via signaling pathways and dysregulation of oncogenes or tumor suppressor 
genes [1]. These possible common mechanisms of metal-induced carcinogenicity with unique 
discrepancies regarding to specific metals are discussed in more detail. 
2. Overall Mechanisms of Metal-Induced Genotoxicity and Carcinogenicity 
Common mechanisms of various carcinogenic metals that induce oxidative stress, impair DNA 
repair systems, and interrupt signaling pathways are related to cell proliferation and account for the 
majority of metal-induced carcinogenicity (Figure 1) [1]. Unique mechanisms of specific carcinogenic 
metals cannot be excluded: such as substitution for inorganic phosphate in oxidative phosphorylation 
pathways by arsenic; disruption of cell-cell adhesion by cadmium; direct DNA binding of trivalent 
chromium; and interference with DNA methylation and histone acetylation by nickel. 
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Figure 1. Scheme showing (A) main mechanisms and (B) plausible biomarkers with the 
proposed means of risk prediction for metal-mediated carcinogenicity. 
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2.1. Induction of Oxidative Stress, a Causative Source for Metal-Toxicity 
Induction of oxidative stress is a remarkable phenomenon to explain metal-induced genotoxicity and 
mutagenicity. Several carcinogenic metals such as arsenic, cobalt, chromium, lead, mercury, and nickel 
induce redox reactions in living systems. These metals induce the production of ROS (e.g., hydroxyl 
peroxide and superoxide radicals) and RNS (e.g., nitric oxide, peroxynitrite and S-nitrosothiols) in both 
in vivo and in vitro systems. The generation of hydroxyl radicals has been mostly constituted through 
Fenton- and Haber-Weiss-type reactions. These radicals have rendered oxidative damage to DNA, 
proteins, and lipids. Redox-inert metal cadmium is unable to perform redox reactions in biological 
systems. However, it is able to stimulate oxidative stress as it inhibits antioxidant enzymes (e.g., catalase, 
glutathione peroxidase, glutathione reductase, and superoxide dismutase) through the interaction with 
their thiol groups, both in vivo and in vitro. Cadmium is also capable of replacing copper and iron in 
various cytoplasmic and membrane proteins (e.g., ferritin, apoferritin), leading to an increase in the 
amount of unbound or poorly chelated copper and iron ions inducing oxidative stress via Fenton 
reactions [11,12]. Cadmium treatment resulted in a significant number of cells with DNA single-strand 
breaks and cellular DNA damage [13,14]. Indeed, an animal system administrated with Cd(II) has 
transient oxidative damage [15,16]. Interestingly, a reversal effect of cobalt on free radical generation 
has been observed [17]. Intake of cobalt significantly suppresses the formation of free radical as well as 
oxidation of lipids and proteins. Other than direct DNA damage, ROS at low concentrations functions as 
a mitogenic signal to activate redox-sensitive transcription factors [1,18]. Chronic toxicity from 
persistent exposure to toxic metals leads to their accumulation in living system and becomes a health 
public concern [19–21]. Exposure to metallic compounds with nanoscalesizes, so called nanoparticles, 
such as cobalt and nickel has led to cytotoxic effect in concentration-dependent manner in vitro [22].  
A number of studies have been conducted to investigate adverse effect of various metallic nanoparticles 
or nanomaterials on induction of free radicals as well as their modes of action both in vitro and   
in vivo [23–27]. These findings indicate several types of DNA damage, including generation of 
micronuclei, formation of DNA adduct (8-hydroxy-2-deoxyguanosine), and chromosomal aberrations. 
From, the results of nanoparticles-mediated expression analysis at both mRNA and protein also reveal 
extensive disruption of particular signaling pathways involving apoptosis, cell cycle control, 
embryogenesis, growth, and inflammation [27–31]. 
Therefore, oxidative stress might not only facilitate tumor initiation by mutagenesis but also deplete 
the activities of cellular antioxidant enzymes through the interactions with their thiol groups and 
dysregulate cell growth and proliferation, leading to tumor promotion. This event is predominantly 
dependent on the degree and duration of persistent exposure to carcinogenic metals. Oxidative stress 
phenomenon represent an interesting view of metal-induced carcinogenicity between relatively low 
doses of metals that are capable of inducing tumor initiation and highly cytotoxic doses of metals that 
elicit free radicals and damage to biomolecules. Hence, it is apparent that oxidative stress is not the 
sole causative factor for metal-initiated carcinogenesis but is still considered as potential contributor to 
malignant transformation. 
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2.2. Impairment of DNA Repair Systems and Involvement in Carcinogenesis 
DNA molecules are continuously damaged by environmental stimuli (e.g., UV, chemical toxicants, 
and biological toxins) and endogenous factors formed during oxidative metabolism. Therefore, several 
endogenous DNA repair systems operate continuously with partial overlapping functions. These 
mainly include base excision repair (BER)/single strand break repair, nucleotide excision repair (NER), 
base mismatch repair, and recombinational (double strand break) repair. Most carcinogenic metals, 
except Cr(VI), are weak mutagens in mammalian cells and are often comutagenic due to the acceleration 
of mutagenicity of other genotoxic agents. A closer look reveals conflicting phenomenon under the 
aspect of DNA repair impairment in metal-mediated carcinogenesis: the presence of oxidative damage 
evoked by redox-inert metal like cadmium; discrepancies between low mutagenicity and high 
carcinogenicity for nickel compounds; and synergistic effects of coexposure to non-carcinogenic 
chemical such as polyaromatic hydrocarbons and cobalt [32]. Indeed, recent research has reported that 
some carcinogenic metals at low concentrations are able to inhibit repair of DNA damage generated  
by both endogenous and exogenous factors [1]. Increasing evidence has clarified that DNA repair 
processes are susceptible to carcinogenic metals, including As(III)/As(V), Cd(II), Cr(VI), Ni(II) as 
well as Hg(II) and Pb(II). Individual metals also inhibit selectively with repair systems at different 
steps. In the NER system, Cd(II) and Ni(II) interfere with the recognition of DNA lesions whereas 
Co(II) impairs the incision as well as the polymerization step [32–34]. As(III) inhibits the incision step 
at low concentrations and the ligation step at higher concentrations [34]. These three metals Cd(II), 
Hg(II), and Pb(II)also decrease the incision step [32,35]. A very recent report has documented that 
assembly and disassembly of the NER machinery are disturbed by water soluble Cd(II), as evidence of 
disassembly inhibition of XPA and XPC, principle components in the global genome NER [36]. 
Metalloids such as arsenic in particulate form, methylated arsenites and arsenates, are capable of 
inhibiting BER, NER, and strand break repair in vitro [37–39]. Chromate diminishes NER and 
synergistically augments mutagenicity of benzo[a]pyrene in mammalian cells [40]. A polymorphism 
of OGG1 enzyme involved in the BER process has shown repair susceptibility to chromate in human 
populations [41]. 
Inherited or acquired deficiencies in such repair systems can initiate to malignant growth. Genetic 
defects and polymorphisms in genes of the DNA repair components (e.g., ERCC1, MGMT, MLH1, 
MSH2, MSH6, and XRCC4) are strongly associated with human cancer [42,43]. Consecutive disturbance 
of repair and persistent DNA damage give rise to genomic instability, possibly allowing for aberrant 
cell proliferation and/or imperfect apoptosis. 
2.3. Interruption of Cell Growth Signaling and Its Promotion of Carcinogenesis 
Tumor development is likely attributable to dysregulation of cell growth and differentiation. 
Carcinogenic metals may affect cell growth by mechanisms such as changes in expression of   
growth-related factors and inactivation of growth regulation. Some metals promote several pathways, 
such as the mitogen-activated protein kinase (MAPK) pathways. This involves activation of nuclear 
transcription factors (AP-1, NF-κB, p53, NFAT, and HIF-1) which govern the expression of 
cytoprotective genes in relevance to DNA repair, immune response, cell cycle arrest, and apoptosis. Int. J. Mol. Sci. 2011, 12            
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Toxic metals and ROS probably interact with thiol groups in many types of phosphatases, particularly 
serine/threonine-, phosphotyrosine- and phospholipid-phosphatases, which are oxidized to form disulfide 
bonds [44,45]. This leads to protein conformational changes which in turn up-regulate various 
signaling cascades and result in the activation of particular redox-regulated transcription factors as 
mentioned above. 
Nuclear transcription factor AP-1 has a vital role in cell growth and apoptosis [46]. AP-1 activity is 
induced by the JNK and p38 MAPK cascades in response to particular metals, hydrogen peroxide, 
cytokines, and other stressors [47]. Nuclear factor NF-κB has important functions in several processes, 
notably the inflammatory response, cell transformation, and cell survival [48,49]. Activation of   
NF-κB has been associated with carcinogenesis by external stimuli such as toxic metals, UV, and 
benzo[a]pyrene [48,49]. The influence of metals and ROS on NF-κB activation has been supported by 
the finding that the activation by several stimuli is often blocked by antioxidants, including thiols and 
vitamin E [50,51]. Administration of antioxidant N-acetyl-L-cysteine (NAC) significantly inhibits ROS 
production as well as NF-κB-, p38 MAPK-, and protein kinase C-mediated signaling pathways, 
resulting in abolished inflammation in rats treated with nanoparticles [24]. p53 gene mutations are 
linked to the majority of human cancers [52]. p53 mutation can occur by environmental carcinogens 
such as nickel, cigarette smoke, and UV irradiation [53,54]. Mechanisms of p53 activation in response 
to carcinogenic metals have determined in multiple ways [55,56]. The nuclear factor of activated T cells 
(NFAT) controls cytokine production, muscle growth and differentiation, and angiogenesis  [57,58]. 
Previous studies have determined that various metals such as nickel increase intracellular calcium, 
representing a plausible mode of action for metal-activated NFAT [59]. Certain metals activate NFAT 
not only via a calcium-dependent pathway but also through formation of hydrogen peroxide [60]. 
Hypoxia-induced factor HIF-1 controls precise oxygen homeostasis by modulating expression of several 
cancer-related genes, including heme oxygenase1 and vascular endothelial growth factor [61]. The 
carcinogenic metals such as nickel or chromium and hydrogen peroxide have been known to activate 
HIF-1 [60,62]. In vitro study has reported that nickel activates the HIF-1 based on the substitution of iron 
in the oxygen carrier by nickel, which leads to permanent hypoxia; thus activating HIF1 [60]. 
Indeed, epigenetic mechanisms such as hypo- or hyper-methylation of DNA or altered histone 
acetylation might lead to changes in gene expression patterns. Alteration of gene regulation by 
carcinogenic metals in a persistent manner is linked to tumor manifestations. Some carcinogenic metals 
inhibit tumor suppressor p53 and/or decrease the expression of tumor suppressor genes (e.g., p16 and 
p53) as well as senescence genes. Therefore, metals might enhance cell proliferation by inhibiting 
apoptotic processes and allow for cell adaptation to metal-toxicity. Nickel alters normal growth control 
by distinct epigenetic mechanisms [63]. Recent studies have been conducted in mammalian cells in 
which nickel compounds enhance methylation of cytosine bases and reduce expression of tumor 
suppressor genes, resulting in accelerated cell proliferation. In nickel-induced tumors, DNA 
hypermethylation has been detected with decreased expression of the tumor suppressor genes p16 and 
Fhit. As a second epigenetic mechanism, nickel compounds have been observed to inhibit acetylation 
of several histones followed by chromatin condensation in vitro, probably by the binding of nickel ions 
to histone proteins. Because histone acetylation facilitates the accessibility of transcription factors to 
DNA, inhibition of histone acetylation apparently contributes to silencing of telomeric genes. 
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3. Revisiting Potential Biomarkers for Metal-Genotoxicity and Carcinogenicity: Interference of 
Protein-Protein Interactions with Zinc Finger Proteins 
Approximately 10% of genesencode zinc finger proteins in the human genome with diverse ranges of 
functions, including DNA recognition and repair, RNA packaging, transcriptional activation, regulation 
of apoptosis, and protein folding and assembly [64–67]. Within zinc finger structures in their   
DNA-binding motifs, zinc is complexed to four cysteines (Cys) and/or histidines (His), allowing for 
proper folding of different structural domains and facilitating DNA-protein as well as protein-protein 
interactions [68,69]. Current data on interference with zinc finger DNA repair proteins by toxic metals 
will be summarized. 
Indeed, interactions with zinc finger proteins, notably DNA repair proteins, transcription factors, 
and tumor suppressors, are thought to be more relevant for metal-mediated carcinogenesis rather than 
direct binding to DNA [1]. Possible mechanisms for zinc finger-interference by carcinogenic metals 
include isostructural substitution, replacement with altered geometry, mixed complex formation, and 
catalysis of thiol oxidation [69]. These modes related to metal carcinogenesis are dedicated to the 
altered gene expression [70]. Definite zinc finger proteins might be regarded as predictive direct 
biomarkers for the initiation of cancer (Figure 1). 
3.1. Mammalian DNA Repair Protein XPA 
Xerodermapigmentosum A (XPA) is a prominent protein, containing a single Cys4 zinc finger 
domain, for DNA lesion recognition in NER pathway [71,72]. NER is one of the most versatile repair 
pathways against various bulky DNA lesions, induced by UV light, environmental carcinogens, and 
particular anticancer agents. In the initial step, XPA is a key component in the assembly of the   
pre-incision complex by recruiting other proteins to the damaged DNA site. These include excision 
repair cross complementing protein 1, transcription factor IIH, and replication protein A. XPA binds 
specifically to DNA lesions induced by UVC, benzo[a]pyrene, or cis-platinum [73–75]. XPA contains 
a single zinc finger motif, as part of the minimal DNA-binding domain, in which four Cysresidues 
arecomplexed with zinc. Replacing of these individual Cysleads to a dramatic loss in NER activity [71]. 
Using a gel mobility shift assay, systematic studies focusing onmetal-inhibited XPA binding to a   
UV-irradiated oligonucleotide have shown that DNA binding activity is diminished by adding Cd(II), 
Co(II), and Ni(II) whereas it has not been affected by As(III), Hg(II), or Pb(II) [76] Simultaneous 
treatment with Zn(II) effectively prevents XPA inhibition by Cd(II), Co(II), and Ni(II) [76].Parallel 
experiments with a bacterial form amidopyrimidine-DNA glycosylase (Fpg), a well-studied zinc finger 
protein responsible for BER, have revealed susceptibilities to Cd(II) and Hg(II)but no inhibitory effect 
of the other tested metals [76].This reflects that individual zinc finger proteins have unique sensitivity 
to different toxic metals. Further molecular studies have been conducted using a structural model of 
the 37-peptide XPA zinc finger motif (XPAzf), allowing for competitive analysis of Zn(II) with Cd(II), 
Co(II), and Ni(II) in a quantitative manner [77,78]. In the presence of Ni(II), it has been found to 
promote XPAzf oxidation, resulting in the loss of Zn(II). This might be due to alterations in the 
tetrahedral geometry of the metal site and irreversible formation of intramolecular disulfide bonds 
catalyzed by Ni(II). In the case of Co(II), it demonstrates less effectiveness for Zn(II) substitution, Int. J. Mol. Sci. 2011, 12            
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relative to Ni(II). At excessive Co(II) concentrations, it has been observed to indirectly induce strong 
oxidation of XPAzf. To study of Cd(II), it is possible to substitute Zn(II) in quantitative fashion and 
consequently distort the peptide structure without Cd(II)-mediated oxidation of thiol groups, due to its 
very high binding affinity. These three metals are capable of interfering with XPA in different ways. 
Recent research has reported that soluble cadmium chloride obviously disturbs disassembly of XPA 
and XPC a key initiator in the global genome NER [36]. Collectively, other mechanisms of the 
exacerbated DNA-protein interactions via interference in its zinc finger motif by carcinogenic metals 
remain to be elucidated. 
3.2. Poly (ADP-Ribose)Polymerase(PARP) 
DNA strand break repair protein PARP possesses two separateCys3His1-type zinc finger domains 
with the main role of detecting and signaling DNA strand breaks for enzymatic machinery involved  
in BER [79]. Following DNA strand breakage, PARP catalyzes the addition of long chains   
of poly(ADP-ribose)polymers to target proteins participating in chromatin architecture and DNA 
metabolism [80–82]. This modification step seems to be obligatory for detecting and/or recognizing 
nicked DNA [82,83]. Under mild to moderate genotoxic stimuli, PARP proceeds with the DNA repair 
process through cell cycle arrest and subsequent interaction with DNA repair enzymes [80,82]. PARP 
may be hyperactivated by severe DNA damage which eventually stimulates the apoptotic process [82,84]. 
Furthermore, PARP likely has a profound role in anticancer agent-induced and spontaneous apoptosis; 
however, it is not yet fully clarified [85]. A very recent investigation evaluated inhibitory effects of 
anticancer metal complexes on PARP activity derived from human cancer cells, indicating a strong 
link between PARP inhibition and binding ability of these complexes to the zinc finger motif by  
zinc competition [82]. These data support the concept that zinc displacement with other metals in the 
zinc finger motif yields a reduction in its activity. This result emphasizes that PARP is promising 
mediator involved in drug resistance to cancer cell chemotherapies. PARP activity is reduced in a 
human lymphoma cell line by As(III) [86]. Similar experiments have demonstrated that hydrogen 
peroxide-induced PARP activity in HeLa cells is selectively inhibited by As(II), Co(II), Cd(II), and 
Ni(II) but not by Pb(II) or Hg(II) [68]. However, further molecular studies based on inhibition via 
interactions with the zinc finger motif are necessary. 
3.3. Tumor Suppressor Protein p53 
The p53 protein with Cys3His1-typed zinc finger domain has an important role in DNA repair 
through the NER and genomic stability [87]. p53 controls a number of key events to induce either 
DNA repair processing, cell cycle arrest, or apoptosis via coordinated pathways, depending on the 
physiological state and cell type [87]. Indeed, p53 is activated by multiple forms of stress signals, 
including DNA damage. p53 regulates the transcription of several downstream genes including XPA, 
via its binding to specific response elements, which prevents damaged cells from dividing, leading to 
repair of damaged DNA, or ultimately to cells with severe damage by apoptosis. In addition, p53 
directly interact with particular proteins involved in DNA repair, replication, and transcription [88]. 
Based on its key biochemical property, sequence-specific DNA binding is dependent on metal and 
redox regulation. p53-DNA binding is mediated by tetrahedral co-ordination of zinc with three Cys Int. J. Mol. Sci. 2011, 12            
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and one Hys, suggesting that zinc is required for proper folding of p53 into its native conformation and 
consequent functionality [89]. Selenium compounds, as redox stimulators, may facilitate p53-specific 
DNA binding as well as p53-mediated DNA repair through a redox regulation at definite Cys residues, 
in the presence of DNA damage [90–95]. Co(II) and Ni(II) impair p53-DNA binding capacity and 
inhibit cell cycle arrest [96], due to the disruption of p53 native conformation. Water-soluble cadmium 
chloride and particulate cadmium oxide compounds also altered p53 conformation at the zinc finger 
motif in human cells [36,97]. 
Taken together, zinc finger motifs participate in protein–DNA and protein-protein interactions in 
several groups of proteins, including those involved in DNA repair, transcription, and tumor suppression. 
Definite carcinogenic metals, such as arsenic, cadmium, cobalt, lead, and nickel differentially inhibit 
these zinc finger proteins, leading to distorted zinc finger domains and consequent dysfunction of the 
proteins. Therefore, this reactivity could be considered as a plausible molecular mechanism in 
carcinogenesis. Indeed, very limited information has established reference concentration (RfC) or 
reference dose (RfD) for the exposure of individual carcinogenic metals, indicating no confident 
association between metal levels and their carcinogenicities in humans. Besides direct measurement  
of metal levels in human specimens, the use of these zinc finger proteins as genetic factors could 
predict risk of carcinogenesis with a higher specificity based on changes in their binding constants or 
stability constants when complexed with either Zn(II) or thiol-typed antioxidants (e.g., glutathione 
andthioredoxin) [16,66]. Alternatively, assessing DNA repair capacity via assays of particular enzymes 
(DNA polymerase β “β pol” and XPG or ERCC5) involved in definite zinc finger protein-modulated 
repair pathways, with the use of protein extracts from human tissues or cells, might be useful for 
partially evaluating cancer risk [98,99]. 
4. Enhancement of Antioxidant Defense Systems Responsible for Reducing Metal-Induced 
Carcinogenicity  
The interactions of various carcinogenic metals with biological components are quite complex. The 
cellular components in antioxidant defenses are vitalas they scavenge and balance prooxidants, ROS 
and RNS, which are attributable to the activities of antioxidant enzymes as well as the action of  
non-enzymatic antioxidants (Figure 1), thus providing maximal protection fat biological sites. The most 
efficient enzymatic antioxidants are comprised of catalase, glutathione peroxidase, and superoxide 
dismutase [10,100]. Non-enzymatic antioxidants include vitamin C, vitamin E, thiol antioxidants 
(glutathione, thioredoxin, and lipoic acid), natural flavonoids, melatonin, and selenium [101]. Some 
antioxidants such as vitamin C act in a hydrophilic phase, some such as vitamin E in a hydrophobic 
phase, and others such as α-lipoic acid act in both phases. Indeed, the capacity to regenerate one 
antioxidant by another, called an antioxidant network is driven by redox potentials [102]. There is 
correlation between enhanced ROS levels and abolished activities of both enzymatic and   
non-enzymatic antioxidants in tumor cells. 
4.1. Enzymatic Antioxidants and Their Physiological Response to Metallotoxicity 
Several studies have documented altered levels of reduced glutathione and glutathione peroxidase in 
animals following arsenic exposure [4,103,104]. In the case of cadmium, changes in antioxidant enzymes Int. J. Mol. Sci. 2011, 12            
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activities (e.g., catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, and   
Cu, Zn-superoxide dismutase) have been determined in rats [105,106]. Lead exposure results in 
alterations of oxidative stress markers (catalase, superoxide dismutase and glutathione peroxidase, and 
glutathione reductase) as well as the level of reduced glutathione in animal models [107,108]. 
Although adding antioxidant enzymes such as catalase and superoxide dismutase (75 and 150 μg/mL, 
respectively) does not appear to protect lymphocytes against organic mercury-induced genotoxicity  
in vitro [109,110], epidemiological observations have revealed that the activity of these enzymes 
changes in exposed populations with resulting genotoxic alterations [109,111]. These data emphasize 
that chronic exposure to relatively low levels of mercury may inhibit antioxidant enzymatic activity 
due to persistent oxidative stress [109,111]. This phenomenon might represent an important peripheral 
target for mercury toxicity in exposed populations. 
4.2. Non-Enzymatic Antioxidants and Their Melioration towards Carcinogenesis 
Supplementation with vitamin C and/or vitamin E is protective against cadmium intoxication as 
shown by the decrease in ROS level in rat testicular tissues. Dietary uptake of a combination of these 
vitamins restores normal testicular function in cadmium-treated rats [112]. Effective antioxidants   
and free radical scavengers such as melatonin, methyl gallate, and quercetin also have cytoprotective 
effect against cadmium toxicity by reducing lipid peroxidation and maintaining physiological 
homeostasis [113–115]. Inhaled cobalt particles interact primarily with surfactants and antioxidants on 
the lung surface [116]. Reduced glutathione, a ROS scavenger, acts as one of the first lines of defense 
against lung injury due to formation of excessive ROS. The extent of the reduction in thiol concentration 
is correlated with the amount of dust and consequent surface area exposed. Co(II) exposure also results 
in the depletion of intracellular ascorbate [117]. Intriguingly, the influx of ascorbate is inhibited by 
cobalt whereas the efflux is metal-independent process. Both ascorbate and reduced glutathione can 
scavenge superoxide and hydroxyl radicals, initiated by cobalt  [116,118]. Additionally, reduced 
glutathione and Cysresidues in proteins also have a prominent role in redox regulation in response to 
cobalt in the form of a cobalt/tungsten (Co/WC) mixture [116,118].  
Previous reports suggest that ascorbate is a primary reducer of Cr(VI) in cells [119–121]. However, 
ascorbate has dual opposing roles in Cr(VI) intoxication, as a protective-antioxidant outside and a 
prooxidant inside of cells. The ascorbate-initiated reduction of Cr(VI) inside cells cause high amounts 
of chromium-DNA adducts, allowing for DNA mutation [120–122]. In addition, Cr(VI)is also reduced 
through non-enzymatic reactions with Cys and glutathione. The primary reductant of Cr(VI)in 
mitochondria seems to be NAD(P)H, resulting in stable Cr(III) with relatively higher DNA affinity 
than that of Cr(VI) [2,122]. 
The majority of lead intoxication is related to glutathione metabolism [4,123]. Lead exposure in 
animal models alters the reduced glutathione level [107,108]. Glutathione is an important substrate, 
which impacts the action of several drugs and toxins via its conjugation in the liver. An increase in the 
incidence of hypertension has been observed following lead exposure in humans, possibly due to 
significant effect of RNS such as nitric oxide [124]. Antioxidants can be utilized to inhibit the 
availability of nitric oxide. Administration of vitamin E (5000 IU/kg) and vitamin C (3 mmol/L of 
drinking water) to hypertensive rats with suppressed glutathione formation abolish shypertension. Zinc Int. J. Mol. Sci. 2011, 12            
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supplementation in lead-treated animals restores superoxide dismutase levels [125], suggesting that 
zinc acts as an antioxidant and a plausible chelating agent toward lead toxicity. Administration of 
selenium prior to lead exposure is plays a protective effect in animals [126]. Selenium elevates reduced 
glutathione, glutathione peroxidase, and superoxide dismutase levels in kidney and liver tissues as well 
as reduced glutathione. Selenium generates a stable lead-selenium complex, implying protective effect 
against lead toxicity. Alpha-lipoic acid is an effective antioxidant with chelating properties. In 
response to lead exposure, alpha-lipoic acid suppresses the deleterious effect of lead on glutathione and 
oxidative stress markers in liver and kidney tissues [127]. 
In studies of mercury-induced toxicity, increased glutathione levels may protect cells by exerting 
antioxidant activity and chelating mercury [109,128], suggesting that glutathione acts as a major line 
of cell defense against mercury toxicity. Previous data also suggest that high levels of intracellular 
glutathione may contribute to neuro protection upon exposure to mercury compounds [129]. In vivo 
research has demonstrated that glutathione levels are also higher in human populations that consume 
methylmercury-contaminated fish (levels of mercury content in hair of 12–15 μg/g) [111]. Furthermore, 
a direct positive relationship between glutathione and mercury levels has been found in the blood. 
Antioxidant substances such as ascorbate also exhibit their protective action against mercury 
genotoxicity in vitro by preventing sister chromatid exchanges and abnormal mitosis [130]. Interestingly, 
a substantial inverse correlation was observed between mercury levels in blood and consumption of 
tropical fruits (particularly vitamin C-rich oranges) in mercury-exposed populations [131]. This reflects 
another aspect of the protective role of the antioxidant compounds.  
Nevertheless, a meta-analysis of randomized controlled trials has revealed inconsistent findings 
between experimental studies (both in vitro and in vivo) and human clinical trials with regard to the 
association between antioxidant supplements and the risk of carcinogenesis, suggesting that experimental 
studies showing the effects of antioxidant substances cannot be directly applied to humans [132] because 
these substances might exert adverse properties or promote carcinogenesis under clinical circumstances. 
Currently, no clinical evidence supports the use of antioxidant supplements for primary and secondary 
prevention of cancer. Although many populations consume antioxidant substances to improve their 
health and prevent cancer, the potential effects (either beneficial or deleterious) of antioxidant 
supplements on human health, particularly in relation to cancer risk, must be emphasized. 
5. Conclusion 
The relevance between metal-induced interference and carcinogenesis in living systems has 
received increasing attention. Understanding the mechanisms underlying toxicity initiated by diverse 
carcinogenic metals and metallic nanoparticles is of great concern. Little is known about toxicity and 
guidelines based on metallic nanoparticles whereas their trend of use has been increasing. Chronic 
exposure to toxic metals via diverse routes into living bodies can cause accumulation and dangerous 
illness [21,133–136]. Among children, toxic metal biomonitoring in physiological tissues such as 
blood and urine may provide adequate assessments to prevent such illness/suffering, leading to severe 
mental retardation [19,21]. Metal carcinogenicity occurs through complex mechanisms and oxidative 
assault, cellular redox homeostasis, DNA repair, and particular signal transduction pathways are 
thought to be interconnected. The interference of toxic metals with zinc finger proteins, notably DNA Int. J. Mol. Sci. 2011, 12            
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repair proteins, is likely to be more relevant for metal-mediated carcinogenesis than for direct 
interactions with DNA [1]. The relevant issue of zinc finger proteins functioning in DNA repair 
systems is also supported by epidemiological observations that a large number of human populations 
with inadequate dietary zinc, even in developed countries, have augmented cancer incidence [16,137]. 
Zinc deficiency probably results in enhanced displacement and lowered restoration of zinc finger 
motifs which are present in zinc finger proteins (e.g., DNA repair enzymes, nuclear transcription 
factors, and tumor suppressors). Hence, a broad spectrum of these zinc finger proteins might be 
regarded as promising biomarkers for risk assessment of environmental and occupational exposure to 
definite carcinogenic metals. Identifying novel markers or a collection of specific markers will be 
further required for developing a test so that the defects will be detected as early as possible. These 
studies will be helpful for further developing a robust risk evaluation and improving public health 
protection. Significant action to reduce cancer incidence relevant to oxidative stress seems to be 
counteracted by non-enzymatic antioxidants cooperating with cellular antioxidant enzymes. The most 
important action of cancer prevention is to minimize exposure to oxidative stressors, particularly 
exogenous sources. 
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